Overview

Clinical Trial to Assess the Safety and Pharmacokinetics of RDG-17012 Capsule and Pradaxa® Capsule in Healthy Male Volunteers

Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
A randomized, open-label, single-dosing, 2x2 crossover study, the safety and pharmacokinetics of RDG-17012 with Pradaxa® in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Huons Co., Ltd.
Huons Co.,Ltd.
Treatments:
Dabigatran